SecBot SecBot

SINT

Sintx Technologies, Inc.
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. DE· CIK 0001269026 Healthcare & Medical Devices
$1.71 +0.15 (+9.62%)
Oct 27 4:00 PM ET · prev $1.56
Market cap
$11.9M
Nano cap
Consensus
Buy
89% Buy or better · 9 analysts
Median target
$9.25
+441% · range $6.00–12.50
Next earnings
Nov 5
in 9 days · EPS est. −$0.31
1 year
−50.6%
from $3.46 · Oct 28
30 days
−14.1%
from $1.99
52-week range
$1.40–4.26
−60% from high · low Jul 24
Avg volume 20D
83.2K
Oct 1 spike 676.1K
Short interest
136.4K
≈1.8% of shares · +36.8%
Days to cover
1.1
at average volume
Insider net
+$27.0K
2 buyers · 0 sellers · 12 mo
New fund stakes
0
Q2 2026 13F · 0 exits
SecBot read MIXED 3 reports · 90 days
Balance 1 bearish · 1 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 5, 2026
Strongest BULLISH SINTX reported preliminary Q3 2026 revenue of $2.2M, exceeding its guidance range of $0.9M-$1.1M and…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • InsidersBULLISH

    2 insiders bought $27.0K at an average $2.91. No open-market sales. Price is 41% below their cost.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 2 trimmed or exited.

  • AnalystsBULLISH

    8 of 9 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate −$0.445 → −$0.307 over 90 days. 1 up, 0 down in 30 days.

  • Short sellersBUILDING

    Short interest +36.8% to 136.4K shares. 1.1 days to cover, ≈1.8% of shares.

  • TrendDOWNTREND

    4% below its 50-day average.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
UBS Group AGDOUBLED11,921$22.3K
MORGAN STANLEYNEAR_EXIT1$2.00
OSAIC HOLDINGS, INC.TRIM1$2.00
UBS Group AGTRIM4,953$12.4K
OSAIC HOLDINGS, INC.DOUBLED2$5.00
VANGUARD GROUP INCADD44,436$171.5K
GEODE CAPITAL MANAGEMENT, LLCADD26,624$102.8K
BANK OF AMERICA CORP /DE/ADD31$120.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

9 analysts
Buy 89% rate it Buy or better
Strong Buy2Buy6Hold1Sell0Strong Sell0
12-month targets · 4 analysts

Price is below the lowest target. Median implies +441%.Targets as of Oct 28, 2026.

Recent actions
DateFirmActionRating
Oct 1, 2026Ascendiant Capital
MAINTAIN
MAINTAINBuy
May 20, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy

Insider ledger

Form 4
$27.0K
bought · 2 insiders
$0
sold · 0 insiders
−41.2%
vs their $2.91 cost
DateInsiderTypeValue
Apr 13, 2026
Elmore Robert Ryan
President
AWARD$14.2K
Mar 16, 2026
Elmore Robert Ryan
President
AWARD107,143 sh
Mar 2, 2026
Lyons Christopher Michael
Director
BUY$21.8K
Feb 25, 2026
Lyons Christopher Michael
Director
BUY$2.2K
Feb 23, 2026
MOYES JAY M
Director
BUY$2.9K
Feb 6, 2026
Trask Kevin
Chief Financial Officer
AWARD60,000 sh
Feb 6, 2026
Honigblum Gregg R.
Chief Investment Officer
AWARD75,000 sh
Feb 6, 2026
Olson Eric K.
Chairman, President and CEO
AWARD100,000 sh

Earnings setup

Estimates
Nov 5
reports in 9 days
−$0.31
EPS estimate, this quarter
+31%
estimate change, 90 days
1↑ 0↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.31-$0.33–-$0.28+11.1%$1.3M
Next Q-$0.34-$0.38–-$0.32+3.3%$1.1M
Current FY-$1.83-$1.94–-$1.67+0.3%$3.2M
Next FY-$1.08-$1.21–-$0.91+16.5%$6.0M

Short side

FINRA· Oct 15, 2026
136,441
shares short
+36.8%
vs prior settlement
1.1
days to cover
≈1.8%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 9, 2026 SEC
SINTX Technologies completed a forced call of its Class B warrants, receiving $2.01M in gross proceeds from exercises…
8-K — Impact 4/10
Oct 1, 2026 SEC
SINTX reported preliminary Q3 2026 revenue of $2.2M, exceeding its guidance range of $0.9M-$1.1M and representing…
8-K — Impact 6/10
Aug 19, 2026 SEC
Sintx Technologies' S-3 shelf registration (File No. 333-298283) became effective on August 18, 2026, allowing the…
EFFECT — Impact 6/10
Aug 13, 2026 Listing status
Listing Status: SINT — Normal (was Deficient)
SiNtx Technologies, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Jun 30, 2026 Inst.
UBS Group AG — DOUBLED
11,921 shares ($22.3K)
Jun 30, 2026 Inst.
MORGAN STANLEY — NEAR_EXIT
1 shares ($2.00)
Apr 13, 2026 Insider
Elmore Robert Ryan was granted 4,910 shares
President @ $2.89 ($14.2K)
Mar 23, 2026 Press
SINTX Technologies announced a clinical milestone with the first human implant of its FDA-cleared SINAPTIC Foot &…
Impact 4/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 5, 2026
Earnings date
SINT Q3 2026 Earnings Scheduled — 2026-11-05
Recent
Aug 13, 2026
Listing
Listing Status: SINT — Normal (was Deficient)
SiNtx Technologies, Inc. - Common Stock | Nasdaq Financial Status Indicator D → N
Aug 11, 2026
Earnings date
SINT Q2 2026 Earnings Scheduled — 2026-08-11
Jul 23, 2026
Press release
SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program
SALT LAKE CITY, Utah, July 23, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced…
Jun 22, 2026
Contract
SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders
SALT LAKE CITY, Utah, June 22, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced…
May 11, 2026
Earnings date
SINT Q1 2026 Earnings Scheduled — 2026-05-11

SecBot reports

9 filings · 1 press release · 1 bullish · 4 bearish · 1 mixed · 3 neutral
All SINT filing & press-release reports (10)